Least developed countries vs Saint Kitts and Nevis: Immunization, Hib3
Immunization, Hib3 over time
- Least developed countries
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 97.0% against 74.4% in Least developed countries, a difference of 22.6%.
That makes Saint Kitts and Nevis's figure about 1.3 times Least developed countries's.
Across all 25 years both countries report, Saint Kitts and Nevis has been ahead every year.
Least developed countries ranks 30th and Saint Kitts and Nevis ranks 29th of 43 groups.
Saint Kitts and Nevis has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.8% | 89.1% | 72.3% | Saint Kitts and Nevis |
| 2010s | 75.5% | 97.2% | 21.7% | Saint Kitts and Nevis |
| 2020s | 74.4% | 96.8% | 22.4% | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Least developed countries or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 97.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hib3 between Least developed countries and Saint Kitts and Nevis?
- 22.6%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Least developed countries and Saint Kitts and Nevis?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Saint Kitts and Nevis rank globally for immunization, hib3?
- Least developed countries ranks 30th and Saint Kitts and Nevis ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.